SCHEMBL4616753

SCHEMBL4616753

Cc1ccc(N(C=O)[C@H]2CCCCN2)cc1C1CCN(Cc2ccc(Sc3ccc(F)c(F)c3)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.40
ADRA1A P35348 3/20 0.40
ALDH1A1 P00352 2/20 0.33
MLNR O43193 6/20 0.33
SIGMAR1 Q99720 3/20 0.33
KDM4E B2RXH2 1/20 0.32
RAB9A P51151 1/20 0.32
OPRD1 P41143 1/20 0.31
CCR5 P51681 1/20 0.30
HTT P42858 1/20 0.30
JAK2 O60674 1/20 0.30
JAK1 P23458 1/20 0.30
TYK2 P29597 1/20 0.30
JAK3 P52333 1/20 0.30
PTGIR P43119 1/20 0.30
DRD4 P21917 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636152 0.92 ACHE (0.36) DRD2ADRA1AALDH1A1MLNRPTGIR
SCHEMBL4615165 0.88 PTGIR (0.45) DRD2ADRA1ASIGMAR1HTTPTGIR
SCHEMBL4616735 0.85 DRD2 (0.33) DRD2ADRA1AMLNRSIGMAR1DRD4
Hydrochloric Acid SCHEMBL4853095 0.81 DRD2 (0.45) DRD2ADRA1AALDH1A1MLNROPRD1
Hydrochloric Acid SCHEMBL4847788 0.81 DRD2 (0.45) DRD2ADRA1AALDH1A1MLNROPRD1
SCHEMBL4618086 0.76 DRD2 (0.47) DRD2ADRA1AALDH1A1SIGMAR1HTT
SCHEMBL4617031 0.74 MEN1 (0.38) DRD2ADRA1AALDH1A1KDM4EDRD4
SCHEMBL4808233 0.72 DRD2 (0.57) DRD2ADRA1AALDH1A1MLNRSIGMAR1
SCHEMBL4636221 0.71 ACHE (0.38) DRD2ADRA1A
Hydrochloric Acid SCHEMBL4853040 0.71 DRD2 (0.44) DRD2ADRA1AALDH1A1MLNROPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139555-A1 Arylthiobenzylpiperidine Derivatives H. LUNDBECK A/S (DK) 2008-06-12 US disclosed
US-7329656-B2 Arylthiobenzylpiperidine derivatives H. LUNDBECK A/S (DK) 2008-02-12 US disclosed
EP-1799223-A4 ARYLTHIOBENZYLPIPERIDINE DERIVATES LUNDBECK & CO AS H (DK) 2008-01-23 EP disclosed
EP-1799223-A2 ARYLTHIOBENZYLPIPERIDINE DERIVATES H.Lundbeck A/S (DK) 2007-06-27 EP disclosed
WO-2006041635-A2 ARYLTHIOBENZYLPIPERIDINE DERIVATIVES H. LUNDBECK A/S (DK) 2006-04-20 WO disclosed
US-20060079683-A1 Arylthiobenzylpiperidine derivatives H. LUNDBECK A/S (DK) 2006-04-13 US disclosed
US-20060079523-A1 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent H. LUNDBECK A/S 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079523-A1 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent MCHR1, MTNR1A, MTNR1B DRD2 156/4885ADRA1A 75/4885ALDH1A1 404/4885
US-20080139555-A1 Arylthiobenzylpiperidine Derivatives MCHR1, MC4R, MCHR2 DRD2 210/4885ADRA1A 54/4885ALDH1A1 332/4885
US-20060079683-A1 Arylthiobenzylpiperidine derivatives MCHR1, MC4R, MCHR2 DRD2 217/4885ADRA1A 50/4885ALDH1A1 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.